VIDEO: Clinicians ‘should continue to pay attention’ to T-DXd side effects in breast cancer

CHICAGO — In this video, Jame Abraham, MD, discusses a secondary safety analysis of the DESTINY-Breast05 study, with particular focus on clinical and demographic risk factors for interstitial lung disease and radiation pneumonitis.Findings from the analysis, which included patients with residual invasive HER2-positive early breast cancer and high risk for recurrence, were presented at ASCO